CN109880824A - 一种通用型核酸提取试剂盒及其使用方法 - Google Patents
一种通用型核酸提取试剂盒及其使用方法 Download PDFInfo
- Publication number
- CN109880824A CN109880824A CN201910274779.9A CN201910274779A CN109880824A CN 109880824 A CN109880824 A CN 109880824A CN 201910274779 A CN201910274779 A CN 201910274779A CN 109880824 A CN109880824 A CN 109880824A
- Authority
- CN
- China
- Prior art keywords
- reagent
- nucleic acid
- concentration
- magnetic bead
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 77
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 77
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 77
- 238000000034 method Methods 0.000 title claims abstract description 34
- 239000000284 extract Substances 0.000 title claims abstract description 31
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 109
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 34
- 229910021645 metal ion Inorganic materials 0.000 claims abstract description 16
- 239000000203 mixture Substances 0.000 claims abstract description 16
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000007864 aqueous solution Substances 0.000 claims abstract description 11
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims abstract description 9
- 150000002357 guanidines Chemical class 0.000 claims abstract description 7
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 6
- 230000005291 magnetic effect Effects 0.000 claims description 39
- 239000011324 bead Substances 0.000 claims description 34
- 241000700605 Viruses Species 0.000 claims description 18
- 239000002480 mineral oil Substances 0.000 claims description 13
- 235000010446 mineral oil Nutrition 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 108010067770 Endopeptidase K Proteins 0.000 claims description 10
- 238000010521 absorption reaction Methods 0.000 claims description 9
- 238000005336 cracking Methods 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 6
- 230000003612 virological effect Effects 0.000 claims description 6
- 239000001509 sodium citrate Substances 0.000 claims description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical group O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 229920002477 rna polymer Polymers 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 2
- 230000000536 complexating effect Effects 0.000 claims 1
- 239000008139 complexing agent Substances 0.000 claims 1
- YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical group N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 239000004575 stone Substances 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims 1
- 230000008901 benefit Effects 0.000 abstract description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 28
- 238000000605 extraction Methods 0.000 description 22
- 239000000243 solution Substances 0.000 description 22
- 238000001514 detection method Methods 0.000 description 20
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 12
- 238000012360 testing method Methods 0.000 description 10
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000001133 acceleration Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 229960004106 citric acid Drugs 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 241000725303 Human immunodeficiency virus Species 0.000 description 3
- 239000005662 Paraffin oil Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 238000000197 pyrolysis Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 229960004543 anhydrous citric acid Drugs 0.000 description 2
- 229960000935 dehydrated alcohol Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical group SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- FBBDOOHMGLLEGJ-UHFFFAOYSA-N methane;hydrochloride Chemical compound C.Cl FBBDOOHMGLLEGJ-UHFFFAOYSA-N 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- -1 trihydroxy methyl amino Chemical group 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910274779.9A CN109880824B (zh) | 2019-04-08 | 2019-04-08 | 一种通用型核酸提取试剂盒及其使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910274779.9A CN109880824B (zh) | 2019-04-08 | 2019-04-08 | 一种通用型核酸提取试剂盒及其使用方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109880824A true CN109880824A (zh) | 2019-06-14 |
CN109880824B CN109880824B (zh) | 2021-03-23 |
Family
ID=66936368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910274779.9A Active CN109880824B (zh) | 2019-04-08 | 2019-04-08 | 一种通用型核酸提取试剂盒及其使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109880824B (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107043766A (zh) * | 2017-02-08 | 2017-08-15 | 上海纽思格生物科技有限公司 | 一种即用型的核酸磁珠提取试剂 |
CN107201360A (zh) * | 2016-03-18 | 2017-09-26 | 康盈创新生物技术(北京)有限公司 | 一种用于病毒基因组核酸快速提取试剂法 |
CN107254463A (zh) * | 2017-06-20 | 2017-10-17 | 迈克生物股份有限公司 | 用于提取丙型肝炎病毒rna的试剂盒 |
CN107663521A (zh) * | 2016-07-28 | 2018-02-06 | 深圳华大基因股份有限公司 | 血浆游离核酸提取试剂盒及其应用 |
CN109182335A (zh) * | 2018-10-17 | 2019-01-11 | 广州奕昕生物科技有限公司 | 一种病毒核酸提取试剂盒 |
CN109207476A (zh) * | 2018-10-26 | 2019-01-15 | 王煜 | 一种尿液游离dna提取试剂盒及提取方法 |
CN109722431A (zh) * | 2019-01-21 | 2019-05-07 | 上海科华生物工程股份有限公司 | 一种基于磁珠法的无醇病毒核酸提取试剂盒 |
-
2019
- 2019-04-08 CN CN201910274779.9A patent/CN109880824B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107201360A (zh) * | 2016-03-18 | 2017-09-26 | 康盈创新生物技术(北京)有限公司 | 一种用于病毒基因组核酸快速提取试剂法 |
CN107663521A (zh) * | 2016-07-28 | 2018-02-06 | 深圳华大基因股份有限公司 | 血浆游离核酸提取试剂盒及其应用 |
CN107043766A (zh) * | 2017-02-08 | 2017-08-15 | 上海纽思格生物科技有限公司 | 一种即用型的核酸磁珠提取试剂 |
CN107254463A (zh) * | 2017-06-20 | 2017-10-17 | 迈克生物股份有限公司 | 用于提取丙型肝炎病毒rna的试剂盒 |
CN109182335A (zh) * | 2018-10-17 | 2019-01-11 | 广州奕昕生物科技有限公司 | 一种病毒核酸提取试剂盒 |
CN109207476A (zh) * | 2018-10-26 | 2019-01-15 | 王煜 | 一种尿液游离dna提取试剂盒及提取方法 |
CN109722431A (zh) * | 2019-01-21 | 2019-05-07 | 上海科华生物工程股份有限公司 | 一种基于磁珠法的无醇病毒核酸提取试剂盒 |
Non-Patent Citations (1)
Title |
---|
李海洋等: "硅羟基磁珠的制备及全基因组DNA提取优化", 《生物技术通报》 * |
Also Published As
Publication number | Publication date |
---|---|
CN109880824B (zh) | 2021-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109913447A (zh) | 游离dna提取富集试剂盒及游离dna提取方法 | |
EP4056714B1 (en) | Detection of sars-cov-2 in a plurality of biological samples | |
CN107663521A (zh) | 血浆游离核酸提取试剂盒及其应用 | |
CN111235316A (zh) | 鉴定新型冠状病毒的引物探针及在三重荧光rpa的应用 | |
CN108410951B (zh) | 一种新的核酸提取试剂及其应用 | |
JP2004509648A (ja) | 非病原性又は病原性インフルエンザaサブタイプh5ウイルス検出キット | |
CN112226432B (zh) | 一种磁珠法快速核酸提取试剂盒及其应用 | |
CN1997895A (zh) | 乙型肝炎病毒的检测方法 | |
CN109762874B (zh) | 核酸助沉剂、孕妇血浆游离dna提取试剂盒及方法 | |
CN103184297A (zh) | 一种荧光同步检测肝炎及艾滋病毒核酸的方法及试剂盒 | |
CN105861493A (zh) | 游离dna提取试剂盒及其应用 | |
CN105779649A (zh) | 一种检测禽白血病病毒的免疫pcr试剂盒 | |
CN103695419B (zh) | 一种病毒核酸提取试剂 | |
CN109182335A (zh) | 一种病毒核酸提取试剂盒 | |
CN106191311A (zh) | 一种快速检测豚鼠LCMV、SV、PVM、Reo‑3病毒的多重液相基因芯片方法及试剂 | |
CN111172240A (zh) | 一种核酸释放剂及hpv病毒核酸检测试剂盒 | |
Loeffler et al. | Automated nucleic acid extraction | |
JP2011038903A (ja) | 水溶性アンモニウムポリマーを含有する検体前処理試薬、および検体前処理方法 | |
CN105441425B (zh) | 一种提取rna的提取液和方法 | |
CN114981429A (zh) | 用于dna分离的方法和试剂盒 | |
CN109880824A (zh) | 一种通用型核酸提取试剂盒及其使用方法 | |
CN108841819B (zh) | 用于提取游离dna的试剂盒和方法 | |
CN111719018A (zh) | 新型冠状病毒环介导等温扩增检测芯片及制备和使用方法 | |
CN103627820A (zh) | 一种乙型肝炎病毒的全自动快速核酸检测试剂管及其使用方法 | |
CN115386573A (zh) | 去除血浆中宿主核酸的方法、试剂盒及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20190614 Assignee: Zhuhai Qiao Biotechnology Co.,Ltd. Assignor: Zhuhai Livzon Diagnostics Inc. Contract record no.: X2019990000239 Denomination of invention: Universal type nucleic acid extraction kit and using method thereof License type: Common License Record date: 20191213 |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EC01 | Cancellation of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Zhuhai Qiao Biotechnology Co.,Ltd. Assignor: ZHUHAI LIVZON DIAGNOSTICS Inc. Contract record no.: X2019990000239 Date of cancellation: 20240104 |